AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 93 filers reported holding AVROBIO INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $194,656 | +697.5% | 126,400 | +417.8% | 0.00% | – |
| Q1 2023 | $24,409 | +52.6% | 24,409 | +41.3% | 0.00% | – |
| Q2 2022 | $16,000 | -93.9% | 17,272 | -74.8% | 0.00% | – |
| Q4 2021 | $264,000 | +288.2% | 68,498 | +465.3% | 0.00% | – |
| Q3 2021 | $68,000 | -81.9% | 12,118 | -71.4% | 0.00% | – |
| Q2 2021 | $376,000 | -28.9% | 42,307 | +1.5% | 0.00% | – |
| Q1 2021 | $529,000 | -50.7% | 41,693 | -45.8% | 0.00% | – |
| Q4 2020 | $1,072,000 | +422.9% | 76,944 | +483.6% | 0.00% | – |
| Q1 2020 | $205,000 | +29.7% | 13,185 | +17.7% | 0.00% | – |
| Q3 2019 | $158,000 | – | 11,203 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 4,520,863 | $5,968,000 | 0.76% |
| Aisling Capital Management LP | 1,009,779 | $1,333,000 | 0.72% |
| MPM BioImpact LLC | 647,918 | $855,000 | 0.23% |
| GMT CAPITAL CORP | 2,594,914 | $3,425,000 | 0.22% |
| New Leaf Venture Partners, L.L.C. | 315,550 | $417,000 | 0.21% |
| GSA CAPITAL PARTNERS LLP | 338,422 | $447,000 | 0.06% |
| Penn Mutual Asset Management, LLC | 37,306 | $49,000 | 0.06% |
| Eversept Partners, LP | 295,369 | $389,887 | 0.03% |
| XTX Topco Ltd | 23,289 | $31,000 | 0.01% |
| Colonial River Wealth Management, LLC | 17,636 | $23,000 | 0.01% |